Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.

The Nova Scotia government communications agency is being restructured to provide better integration between government policy, planning, operations and communications, says the minister responsible ...